{"DataElement":{"publicId":"4379767","version":"1","preferredName":"Laboratory Procedure Absolute Neutrophil Count Eligibility Determination Code Indicator","preferredDefinition":"The coded yes/no/not applicable indicator whether a medical procedure has been performed that involves testing a sample of blood for the absolute neutrophil count, the real number of white blood cells (WBC) that are neutrophils and is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"LAB_ANC_ELG_CD_IND","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2778202","version":"1","preferredName":"Laboratory Procedure Absolute Neutrophil Count Eligibility Determination","preferredDefinition":"information related to the medical procedure that involves testing a sample of blood for the absolute neutrophil count, the real number of white blood cells (WBC) that are neutrophils and is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"LAB_ANC_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778200","version":"1","preferredName":"Absolute Neutrophil Count Eligibility Determination","preferredDefinition":"The real number of white blood cells (WBCs) that are neutrophils. The ANC is derived by multiplying the WBC count times the percent of neutrophils in the differential WBC count; the percent of neutrophils consists of the segmented (fully mature neutrophils) + the bands (almost mature neutrophils). The normal range for the ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C63321:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absolute Neutrophil Count","conceptCode":"C63321","definition":"The real number of white blood cells (WBC) that are neutrophils. It is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count. The normal range for ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5571BFEC-EDBC-1B09-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5571BFEC-EDCD-1B09-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298541","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.","longName":"YES_NO_NA_CD_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"X","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C223-0627-E040-BB89AD432C31","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C22D-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C237-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298540","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Determination that a value is not relevant in the current context.:A system of numbered categories for representation of data.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3298540v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C1F2-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTMS:Clinical Trials Monitoring Service","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C203-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"MAESKEB","dateModified":"2016-01-20","changeDescription":"Created to support Theradex design of CRFs for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876352","version":"1","longName":"Inclusion Criteria","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876425","version":"1","longName":"Laboratory Data (including serologic/viral status)","context":"Theradex"}]},{"publicId":"3876594","version":"1","longName":"Theradex","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876603","version":"1","longName":"Theradex - CTMS 3.14","context":"Theradex"}]}],"AlternateNames":[{"name":"LAB_ANC_ELG_CD_IND","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"Is pre-study absolute neutrop","type":"Preferred Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl?","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1.5 x 109/L?","url":null,"context":"Theradex"},{"name":"Theradex-1","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1.2 X 10^9/L?","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1 x 10^9/L?","url":null,"context":"Theradex"},{"name":"Theradex - 4","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 5","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1.5 x 10^9/L?","url":null,"context":"Theradex"},{"name":"Theradex - 6","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,200/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 7","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than 500/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 8","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than 1,000/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 12","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1.5 x 10^9/L? ","url":null,"context":"Theradex"},{"name":"Theradex-10","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,000/mcl?","url":null,"context":"Theradex"},{"name":"Theradex - 16","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, within 2 weeks of randomization?","url":null,"context":"Theradex"},{"name":"Theradex - 13","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, independent of growth factor support for at least 14 days prior to screening?","url":null,"context":"Theradex"},{"name":"Theradex - 14","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,000/mcl, without growth factors within 2 weeks of initiation of treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 17","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl within 28 days prior to administration of therapy?","url":null,"context":"Theradex"},{"name":"Theradex - 18","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,500/mcL or if neutropenia is related to bone marrow involvement with lymphoma, is the  absolute neutrophil count greater than or equal to 1,000/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 19","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, within 7 days before starting treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 20","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000 cells/mm3 without growth factors (within 14 days of enrollment)?","url":null,"context":"Theradex"},{"name":"Theradex - 21","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000/mcL, unless there is documented bone marrow involvement by lymphoma?","url":null,"context":"Theradex"},{"name":"Theradex - 22","type":"Alternate Question Text","description":"Is screening visit absolute neutrophil count greater than or equal to 1,000/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 15","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1000/mm3?","url":null,"context":"Theradex"},{"name":"Theradex - 23","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, without granulocyte-colony stimulating (GCSF) factor support?","url":null,"context":"Theradex"},{"name":"Theradex - 9","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/uL?","url":null,"context":"Theradex"},{"name":"Theradex - 25","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1.0 x 10^9/L (unless decreased due to bone marrow involvement with lymphoma)?","url":null,"context":"Theradex"},{"name":"Theradex - 24","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than the lower limit of normal (LLN)?","url":null,"context":"Theradex"},{"name":"Theradex - 27","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to institutional LLN?","url":null,"context":"Theradex"},{"name":"Theradex - 26","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, within 8 days of enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 28","type":"Alternate Question Text","description":"Is pre-study peripheral absolute neutrophil count (ANC) greater than or equal to 750/mm3 (0.75x10e9/L)?","url":null,"context":"Theradex"},{"name":"Theradex - 30","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl independent of transfusion, within 14 days prior to enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 29","type":"Alternate Question Text","description":"Does patient have pre-study absolute neutrophil count (ANC) greater than or equal to 1,000/mcl within 14 days of randomization/enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 32","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,500/mcL, within 14 days prior to treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 31","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000/mcL, independent of granulocyte- and granulocyte/macrophage colony stimulating factor (G-CSF and GM-CSF) support for at least 1 week and of pegylated G-CSF for at least 2 weeks at screening?","url":null,"context":"Theradex"},{"name":"Theradex - 33","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1.5 K/cumm within 14 days of enrollment and no administration of G-CSF within 1 week prior to screening assessment?","url":null,"context":"Theradex"},{"name":"Theradex - 34","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000/mcL unless documented bone marrow involvement in which case lower values may be allowed?","url":null,"context":"Theradex"},{"name":"Theradex - 35","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) within 2 weeks of enrollment greater than or equal to 1,500/mcl?","url":null,"context":"Theradex"},{"name":"Theradex - 36","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 500/mcl?","url":null,"context":"Theradex"},{"name":"Theradex - 37","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,000/mcl or is ANC greater than or equal to 0.75 x 10e9/L if there is documented lymphomatous involvement of the bone marrow as assessed by bone marrow biopsy within 90 days prior to registration?","url":null,"context":"Theradex"},{"name":"Theradex - 38","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcl within 14 days of study registration, without granulocyte-colony stimulating (GCSF) factor support?","url":null,"context":"Theradex"},{"name":"Theradex - 39","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1.5 x 10^9/L?","url":null,"context":"Theradex"},{"name":"Theradex - 40","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/ mm3?","url":null,"context":"Theradex"},{"name":"Theradex - 41","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,500/mcL?","url":null,"context":"Theradex"},{"name":"Theradex - 42","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count greater than or equal to 1,000/mcL (greater than 500 if BM clonal plasma cell involvement is greater than 50%)?","url":null,"context":"Theradex"},{"name":"Theradex - 43","type":"Alternate Question Text","description":"Is pre-study absolute neutrophil count (ANC) greater than or equal to 1,500/mcL?","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD3B1E00-3268-A136-E040-BB89AD4324EB","latestVersionIndicator":"Yes","beginDate":"2014-07-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-07-02","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":"Theradex_ghd_07-02-14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}